TNF-α regulates mouse fetal hepatic maturation induced by oncostatin M and extracellular matrices

Hepatology

Volumn 40, Issue 3, 2004, Pages 527-536

  Kamiya, Akihide ^a   Gonzalez, Frank J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; CYCLIN A; CYCLIN A2; CYTOKINE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MATRIGEL; ONCOSTATIN M; TUMOR NECROSIS FACTOR ALPHA; TYROSINE AMINOTRANSFERASE; UNCLASSIFIED DRUG; COLLAGEN; DNA BINDING PROTEIN; HEPATOCYTE NUCLEAR FACTOR 4; INTERLEUKIN 6; LAMININ; LEUKOCYTE ANTIGEN; MESSENGER RNA; OSM PROTEIN, MOUSE; PEPTIDE; PHOSPHOPROTEIN; PROTEOGLYCAN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIVISION; CELL FUNCTION; CELL INTERACTION; CELL MATURATION; CULTURE MEDIUM; DOWN REGULATION; EXTRACELLULAR MATRIX; FETUS DEVELOPMENT; GENE EXPRESSION REGULATION; HOMEOSTASIS; LIVER DEVELOPMENT; LIVER METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; ANIMAL; APOPTOSIS; CELL CYCLE; DRUG COMBINATION; GENETIC TRANSCRIPTION; GENETICS; LIVER; PHYSIOLOGY; PRENATAL DEVELOPMENT;

ANIMALS; ANTIGENS, CD; APOPTOSIS; CELL CYCLE; CELLS, CULTURED; COLLAGEN; DNA-BINDING PROTEINS; DRUG COMBINATIONS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEPATOCYTE NUCLEAR FACTOR 4; INTERLEUKIN-6; LAMININ; LIVER; MICE; ONCOSTATIN M; PEPTIDES; PHOSPHOPROTEINS; PROTEOGLYCANS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4544382508     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20362     Document Type: Article

References (42)

1. Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 1996;334:1717-1725.
2. Aggarwal BB, Natarajan K. Tumor necrosis factors: developments during the last decade. Eur Cytokine Netw 1996;7:93-124.
3. Shelly LL, Tynan W, Schmid W, Schutz G, Yeoh GC. Hepatocyte differentiation in vitro: initiation of tyrosine aminotransferase expression in cultured fetal rat hepatocytes. J Cell Biol 1989;109:3403-3410.
4. Orkin SH. Development of the hematopoietic system. Curr Opin Genet Dev 1996;6:597-602.
5. Miyajima A, Kinoshita T, Tanaka M, Kamiya A, Mukouyama Y, Hara, T. Role of Oncostatin M in hematopoiesis and liver development. Cytokine Growth Factor Rev 2000;11:177-183.
6. Douarin NM. An experimental analysis of liver development. Med Biol 1975:53:427-455.
7. Houssaint E. Differentiation of the mouse hepatic primordium. I. An analysis of tissue interactions in hepatocyte differentiation. Cell Differ 1980;9:269-279.
8. Greengard, O. The developmental formation of enzymes in rat liver. In: Litwack G, ed. Biochemical Actions of Hormones. New York: Academic Press Inc., 1970:53-87.
9. Haber BA, Chin S, Chuang E, Buikhuisen W, Naji A, Taub R. High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes. J Clin Invest 1995;95:832-841.
10. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997;276:60-66.
11. Fausto N. Liver regeneration. J Hepatol 2000;32:19-31.
12. Yamada Y, Fausto N, Kirillova I, Peschon JJ. Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Am J Pathol 1998;152:1577-1589.
13. Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A 1997;94:1441-1446.
14. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995;376:167-170.
15. Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 1999;284:321-325.
16. Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, et al. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med 1999;189:1839-1845.
17. Tanaka M, Fuentes ME, Yamaguchi K, Durnin MH, Dalrymple SA, Hardy KL, et al. Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity 1999;10:421-429.
18. Bonnard M, Mirtsos C, Suzuki S, Graham K, Huang J, Ng M, et al. Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J 2000;19:4976-4985.
19. Rudolph D, Yeh WC, Wakeham A, Rudolph B, Nallainathan D, Potter J, et al. Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev 2000;14:854-862.
20. Rosenfeld ME, Prichard L, Shiojiri N, Fausto N. Prevention of hepatic apoptosis and embryonic lethality in RelA/TNFR-1 double knockout mice. Am J Pathol 2000;156:997-1007.
21. Kamiya A, Kinoshita T, Ito Y, Matsui T, Morikawa Y, Senba E, et al. Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer. EMBO J 1999;18:2127-2136.
22. Kamiya A, Kojima N, Kinoshita T, Sakai Y, Miyajma A. Maturation of fetal hepatocytes in vitro by extracellular matrices and oncostatin M: induction of tryptophan oxygenase. HEPATOLOGY 2002;35:1351-1359.
23. Kinoshita T, Sekiguchi T, Xu MJ, Ito Y, Kamiya A, Tsuji K, et al. Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis. Proc Natl Acad Sci U S A 1999;96:7265-7270.
24. Nagasawa T, Tachibana K, Kishimoto T. A novel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: their functions in development, hematopoiesis and HIV infection. Semin Immunol 1998;10:179-185.
25. Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 2001;21:1393-1403.
26. Lee YH, Sauer B, Johnson PF, Gonzalez FJ. Disruption of the c/ebp alpha gene in adult mouse liver. Mol Cell Biol 1997;17:6014-6022.
27. Kamiya A, Inoue Y, Gonzalez FJ. Role of the hepatocyte nuclear factor 4alpha in control of the pregnane X receptor during fetal liver development. HEPATOLOGY 2003;37:1375-1384.
28. Graham FL, Prevec L. Methods for construction of adenovirus vectors. Mol Biotechnol 1995;3:207-220.
29. Diehl AM. Cytokine regulation of liver injury and repair. Immunol Rev 2000;174:160-171.
30. Matsui T, Kinoshita T, Hirano T, Yokota T, Miyajima A. STAT3 down-regulates the expression of cyclin D during liver development. J Biol Chem 2002;277:36167-36173.
31. Zhou T, Mountz JD, Kimberly RP. Immunobiology of tumor necrosis factor receptor superfamily. Immunol Res 2002;26:323-336.
32. Bradham CA, Qian T, Streetz K, Trautwein C, Brenner DA, Lemasters JJ. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol Cell Biol 1998;18:6353-6364.
33. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, Wendel A. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. J Immunol 1994;153:1778-1788.
34. Pierce RH, Campbell JS, Stephenson AB, Franklin CC, Chaisson M, Poot M, et al. Disruption of redox homeostasis in tumor necrosis factor-induced apoptosis in a murine hepatocyte cell line. Am J Pathol 2000;157:221-236.
35. Inoue Y, Hayhurst GP, Inoue J, Mori M, Gonzalez FJ. Defective ureagenesis in mice carrying a liver-specific disruption of hepatocyte nuclear factor 4alpha (HNF4alpha). HNF4alpha regulates ornithine transcarbamylase in vivo. J Biol Chem 2002;277:25257-25265.
36. De Fabiani E, Mitro N, Anzulovich AC, Pinelli A, Galli G, Crestani M. The negative effects of bile acids and tumor necrosis factor-alpha on the transcription of cholesterol 7alpha-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4: a novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors. J Biol Chem 2001;276:30708-30716.
37. Ito Y, Matsui T, Kamiya A, Kinoshita T, Miyajima A. Retroviral gene transfer of signaling molecules into murine fetal hepatocytes defines distinct roles for the STAT3 and ras pathways during hepatic development. HEPATOLOGY 2000;32:1370-1376.
38. Iocca HA, Isom HC. Tumor necrosis factor-alpha acts as a complete mitogen for primary rat hepatocytes. Am J Pathol 2003;163:465-476.
39. Yamada Y, Webber EM, Kirillova I, Peschon JJ, Fausto N. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor. HEPATOLOGY 1998;28:959-970.
40. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379-1383.
41. Webber EM, Bruix J, Pierce RH, Fausto N. Tumor necrosis factor primes hepatocytes for DNA replication in the rat. HEPATOLOGY 1998;28:1226-1234.
42. Nakamura K, Nonaka H, Saito H, Tanaka M, Miyajima A. Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice. HEPATOLOGY 2004;39:635-644.